Synthesis and Study of New Quinolineaminoethanols as Anti-Bacterial Drugs.

ESKAPEE bacteria Quinoline mycobacterium nosocomial infections tuberculosis

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
18 Jun 2019
Historique:
received: 29 05 2019
revised: 12 06 2019
accepted: 14 06 2019
entrez: 21 6 2019
pubmed: 21 6 2019
medline: 21 6 2019
Statut: epublish

Résumé

The lack of antibiotics with a novel mode of action associated with the spread of drug resistant bacteria make the fight against infectious diseases particularly challenging. A quinoline core is found in several anti-infectious drugs, such as mefloquine and bedaquiline. Two main objectives were set in this work. Firstly, we evaluated the anti-mycobacterial properties of the previous quinolines

Identifiants

pubmed: 31216783
pii: ph12020091
doi: 10.3390/ph12020091
pmc: PMC6630482
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Antimicrob Agents Chemother. 2002 Jun;46(6):1680-7
pubmed: 12019076
Br J Clin Pharmacol. 1992 May;33(5):517-20
pubmed: 1524966
Bioorg Med Chem. 2018 Jul 23;26(12):3573-3579
pubmed: 29858158
Malar J. 2012 Mar 08;11:65
pubmed: 22401346
Antimicrob Agents Chemother. 2000 Apr;44(4):848-52
pubmed: 10722480
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27872065
Chempluschem. 2013 Jul;78(7):642-646
pubmed: 31986621
Clin Infect Dis. 1997 Jan;24 Suppl 1:S121-30
pubmed: 8994791
Tuberc Res Treat. 2014;2014:530815
pubmed: 25580293
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195
pubmed: 27516382
Biomed Pharmacother. 2014 Oct;68(8):1161-75
pubmed: 25458785
J Antibiot (Tokyo). 2013 Nov;66(11):683-6
pubmed: 23820616
Antimicrob Agents Chemother. 2012 Aug;56(8):4202-6
pubmed: 22615290
Sci Adv. 2015 May 08;1(4):e1500106
pubmed: 26601184
Int J Appl Basic Med Res. 2013 Jan;3(1):1-2
pubmed: 23776831
Thorax. 2017 Nov;72(Suppl 2):ii1-ii64
pubmed: 29054853
J Med Chem. 1971 Aug;14(8):680-4
pubmed: 5114063
Proteins. 2007 Jun 1;67(4):971-80
pubmed: 17387738
Int J Infect Dis. 2016 Apr;45:123-34
pubmed: 26976549
Nat Microbiol. 2017 Mar 13;2:17031
pubmed: 28288098
Molecules. 2019 Feb 02;24(3):
pubmed: 30717338

Auteurs

Pierre Laumaillé (P)

AGIR, EA 4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France. pierre.laumaille@etud.u-picardie.fr.

Alexandra Dassonville-Klimpt (A)

AGIR, EA 4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France. alexandra.dassonville@u-picardie.fr.

François Peltier (F)

AGIR, EA 4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France. peltier.francois@chu-amiens.fr.
Department of Bacteriology, Amiens University Hospital, 80054 Amiens, France. peltier.francois@chu-amiens.fr.

Catherine Mullié (C)

AGIR, EA 4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France. catherine.mullie@u-picardie.fr.

Claire Andréjak (C)

AGIR, EA 4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France. andrejak.claire@chu-amiens.fr.
Respiratory and Intensive Care Unit, University Hospital Amiens, 80054 Amiens, France. andrejak.claire@chu-amiens.fr.

Sophie Da-Nascimento (S)

AGIR, EA 4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France. sophie.da-nascimento@u-picardie.fr.

Sandrine Castelain (S)

AGIR, EA 4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France. sandrine.castelain@u-picardie.fr.
Department of Bacteriology, Amiens University Hospital, 80054 Amiens, France. sandrine.castelain@u-picardie.fr.

Pascal Sonnet (P)

AGIR, EA 4294, UFR of Pharmacy, Jules Verne University of Picardie, 80037 Amiens, France. pascal.sonnet@u-picardie.fr.

Classifications MeSH